Progression-Free Survival in Patients With Cholangiocarcinoma With or Without FGF/FGFR Alterations: A FIGHT-202 Post Hoc Analysis of Prior Systemic Therapy Response

Oncogenic fibroblast growth factor receptor (FGFR) gene alterations have been described in patients with cholangiocarcinoma (CCA). This post hoc analysis assessed progression-free survival (PFS) in patients who had received first- or second-line systemic therapy for advanced/metastatic CCA before en...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibeau, Kristen, Féliz, Luis, Lihou, Christine F., Ren, Haobo, Abou-Alfa, Ghassan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200396/
https://www.ncbi.nlm.nih.gov/pubmed/35544727
http://dx.doi.org/10.1200/PO.21.00414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200396/
https://www.ncbi.nlm.nih.gov/pubmed/35544727
http://dx.doi.org/10.1200/PO.21.00414

Ejemplares similares